Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stannous fluoride dentifrice for dentinal hypersensitivity
NCT01827670Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2013
- Primary completion
- May 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of stannous fluoride in dentin hypersensitivity (DH), sponsored by GSK. Started Feb 2013; status: completed.
02
Drugs
stannous fluoride
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT01827670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01827670.